Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Symptom-inhibited Naloxone Induction (SINI) for Opioid Use Disorder
NCT07439549Phase 4Recruiting
- Sponsor
- Pouya Azar Teb
- Start
- Apr 2026
- Primary completion
- Sep 2026
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 4 trial of buprenorphine extended-release injection, naloxone in opioid use disorder (OUD), sponsored by Pouya Azar Teb. Started Apr 2026; status: recruiting.
02
Drugs
buprenorphine extended-release injectionnaloxone
03
Conditions
opioid use disorder (OUD)
Beyond the preview
Go deeper on NCT07439549.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07439549.